WAY-470 is a drug which acts as an agonist at 5-HT2A and 5-HT2C receptors though with lower affinity at 5-HT2B. It has similar binding affinity to 5-HT2A and 5-HT2C but shows functional selectivity for 5-HT2C.[1][2]
Identifiers | |
---|---|
| |
PubChem CID | |
ChemSpider | |
ChEMBL | |
Chemical and physical data | |
Formula | C17H22N2 |
Molar mass | 254.377 g·mol−1 |
3D model (JSmol) | |
| |
|
See also
editReferences
edit- ^ Sabb AL, Vogel RL, Welmaker GS, Sabalski JE, Coupet J, Dunlop J, et al. (May 2004). "Cycloalkyl[b][1,4]benzodiazepinoindoles are agonists at the human 5-HT2C receptor". Bioorganic & Medicinal Chemistry Letters. 14 (10): 2603–2607. doi:10.1016/j.bmcl.2004.02.100. PMID 15109661.
- ^ Lee J, Jung ME, Lee J (November 2010). "5-HT2C receptor modulators: a patent survey". Expert Opinion on Therapeutic Patents. 20 (11): 1429–1455. doi:10.1517/13543776.2010.518956. PMID 20849206. S2CID 32729624.